DUBLIN, Feb. 13, 2017 /PRNewswire/ -- Endo International plc (NASDAQ / TSX: ENDP) will announce its fourth-quarterand full-year 2016 financial results and provide an update on its ongoing corporate strategic review on February 28, 2017. Members of its senior management team will host a conference call and webcast before the U.S. financial
The dial-in number to access the call is U.S./Canada (866) 497-0462, International (678) 509-7598, and the passcode is 58581981. Please dial in 10 minutes prior to the scheduled start time.
A replay of the call will be available from February 28, 2017 at 11:30 a.m. ET until 12:30 p.m. ET on March 14, 2017 by dialing U.S./Canada (855) 859-2056, International (404) 537-3406, and entering the passcode 58581981.
A simultaneous webcast of the call can be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 12:30 p.m. ET on March 14, 2017. The replay can be accessed by clicking the Investor Relations section of the website.
About Endo International plcEndo International plc (NASDAQ / TSX: ENDP) is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical products as well as over-the-counter medications through its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-to-announce-fourth-quarter-and-full-year-2016-financial-results-300406024.html
SOURCE Endo International plc
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All